Skin2Neuron Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
9
- Latest Deal Type
-
Later Stage VC
- (In Progress)
- Investors
-
8
Skin2Neuron General Information
Description
Developer of a regenerative medicine technology intended for the treatment of Alzheimer's and Parkinson's disease. The company specializes in making neurorestorative medicine, and its manufacturing processes allow it to isolate, purify, and expand the rare HFNs in a person's skin, producing a personalized batch of cells and developing protocols for the supply of customizable neuronal cultures for scientific and industry use, enabling healthcare providers to treat patients with neurological disorders and transform health, science, and society.
Contact Information
Website
www.s2n.bioCorporate Office
- 285A Crown Street
- Surry Hills, New South Wales 2010
- Australia
Corporate Office
- 285A Crown Street
- Surry Hills, New South Wales 2010
- Australia
Skin2Neuron Timeline
Skin2Neuron Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Later Stage VC | In Progress | Generating Revenue | ||||
| 4. Secondary Transaction - Private | 15-Aug-2026 | Completed | Generating Revenue | |||
| 3. Accelerator/Incubator | 25-Sep-2025 | Completed | Generating Revenue | |||
| 2. Grant | 17-Apr-2024 | $2M | $5.89M | Completed | Pre-Clinical Trials | |
| 1. Later Stage VC | 09-Apr-2024 | $5.89M | $5.89M | Completed | Pre-Clinical Trials |
Skin2Neuron Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A Preffered | ||||||||
| Preference |
Skin2Neuron Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Skin2Neuron Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Skin2Neuron Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Mooney Investment Group | Venture Capital | Minority | ||
| ANDHealth | Accelerator/Incubator | Minority | ||
| NSW Government (Energy) | Government | |||
| Apex Group | PE-Backed Company | Minority | ||
| Artesian | Venture Capital | Minority |
Skin2Neuron FAQs
-
When was Skin2Neuron founded?
Skin2Neuron was founded in 2019.
-
Where is Skin2Neuron headquartered?
Skin2Neuron is headquartered in Surry Hills, Australia.
-
What is the size of Skin2Neuron?
Skin2Neuron has 9 total employees.
-
What industry is Skin2Neuron in?
Skin2Neuron’s primary industry is Biotechnology.
-
Is Skin2Neuron a private or public company?
Skin2Neuron is a Private company.
-
What is Skin2Neuron’s current revenue?
The current revenue for Skin2Neuron is .
-
How much funding has Skin2Neuron raised over time?
Skin2Neuron has raised $8.29M.
-
Who are Skin2Neuron’s investors?
Mooney Investment Group, ANDHealth, NSW Government (Energy), Apex Group, and Artesian are 5 of 8 investors who have invested in Skin2Neuron.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
